28 / 60
26
POSTERS
| PROGRAMME & EXHIBITION GUIDE
Induction chemotherapy in locally advanced hypopharynx cancer: treatment
outcomes and role of nutritional status
D. Culié (France), K. Benezery, C. Vandersteen, E. Chamorey, M. Ettaiche,
O. Dassonville, G. Poissonnet, F. Peyrade, E. Saada, A. Bozec
PO-075
Is there a dose-response relationship in loco-regional control or survival outcomes
in tonsil cancer?
H.J. Park (Korea Republic of), J.H. Kim, H.G. Wu
PO-076
Chemotherapy with cetuximab for head and neck squamous cell carcinoma: a
retrospective study
L. Pinto (Portugal), M. Teixeira, J. Casalta, L. Khouri, R. Nobre, I. Pires, M. Costa,
B. Gonçalves, R. Silva, H. Gervásio
PO-077
Concurrent cisplatin-radiotherapy with or without induction chemotherapy in
nasopharyngeal carcinoma
W. Mnejja (Tunisia), N. Toumi, R. Bouzguenda, W. Siala, A. Khanfir, M. Ghorbel,
M. Frikha, J. Daoud
PO-078
Base of tongue squamous cell carcinoma as potential nonsurgical pathology
Biological and clinical background
A. Gevorkov (Russian Federation), A. Boyko, L. Zavalishina, A. Chernichenko,
I. Reshetov, R. Plavnik, E. Nosova, E. Khmelevsky
PO-079
Trends in irradiating the mucosae in cervical adenopathies from unknown
primaries
J. Thariat (France), I. Troussier, M. Krengli, J. Miroir, X.S. Sun, S. Shakeel, A. Coutte,
N. Blanchard
PO-080
A longitudinal study of follow-up activities after curative treatment for head and
neck cancer
A.P. Pagh, C.G. Cai Grau (Denmark), J.O. Jens Overgaard
PO-081
Poster
INNOVATIVE TREATMENTS
To quantify dosimetric effects of adaptive radiotherapy for head and neck cancer
E. Kara (Turkey), B. Dirican, A. Yazici
PO-082